With the growing demand for resilient, efficient, and low carbon infrastructure, increasing attention has been directed toward novel materials and ...
A key challenge in structure-based drug design is generating three-dimensional molecules while preserving essential protein-ligand interactions. We propose DiffPharma, a structure-based pharmacophore ...
Deep generative modeling has a strong potential to accelerate drug design. However, existing generative models often face challenges in generalization due to limited data, leading to less innovative ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results